Contoura With Phorcides Compared to Wavefront Optimized LASIK
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-38
SponsorDaniel Terveen
About this trial
Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
Eligibility criteria
Qualifiers
Patients at least age 21 years of age undergoing LASIK eye surgery
Willing and able to comprehend informed consent and complete 1 month post-op visit
Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
Disqualifiers
Patients under 21 years of age
Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
Pachymetry below 490
Trial design
Treatments tested in this trial
- Contoura with Phorcides
- WaveLight Wavefront Optimized
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov